6 Hope Crossword Puzzle for Nurse's Week

Edit Answers
12345678910111213141516171819
Across
  1. 1. Rescue medication given after Methotrexate infusion.
  2. 3. Central line dressings are changed every _______ days or as needed.
  3. 5. Common positive chromosomal abnormality seen in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia - also known as BCR-ABL.
  4. 8. _________ stem cells are the "mother ship" of all cells which then differentiates into your remaining blood cells.
  5. 9. Accrediting body for Blood and Marrow Transplant who we expect to be visiting us soon.
  6. 10. Can be reactivated in the recipient after transplant, and is responsible for conditions such as Post Transplant Lymphoproliferative Disorder (PTLD), Hodgkin Lymphoma, and Hemophagocytic Lymphohistiocytosis (HLH)
  7. 12. What is a common Pediatric diagnosis we treat?
  8. 13. Immunotherapy that targets CD20+ cells in B-Cell Lymphomas
  9. 15. Closed system transfer device used to protect yourself when administering chemotherapy/immunotherapy.
  10. 16. Neutropenia is defined as an ______ of less than 1.5.
  11. 18. Cryoprotectant utilized to maintain cellular therapy products frozen prior to infusion.
  12. 19. Acronym utilized to describe the most common presenting symptoms in Multiple Myeloma
Down
  1. 2. What is the generic name for Cytoxan?
  2. 3. Most common treatment of acute and chronic GVHD which can lead to complications such as hyperglycemia, osteoporosis, and mood changes.
  3. 4. Type of targeted therapy that uses genetically engineered autologous T Cells to target CD19+ B cells.
  4. 6. Extracorporeal _______________ is a type of treatment utilized for chronic GVHD of the skin and lungs that requires a special central venous line.
  5. 7. Tumor lysis labs should be ordered when the patient initiates this oral chemotherapy drug.
  6. 11. The oncology _______ on your IV pump ensures certain guardrails are met when programming high risk medication such as chemotherapy/immunotherapy.
  7. 14. You should never flush/push this drug due to the chance of reaction.
  8. 17. A condition that can occur after an allogeneic stem cell transplant when the donor cells recognize the recipient as foreign.